(HealthDay News) — Use of glucagon-like peptide 1 receptor agonists (GLP-1 RAs) is associated with the risk for retained gastric contents and inadequate bowel preparation during endoscopic procedures, ...
The alert follows an announcement from the US DOJ regarding the indictment of 18 individuals who operated a network of fake online pharmacies and pill mills.
The US Department of Health and Human Services has set a goal that at least 95% of children in kindergarten get 2 doses of the measles-mumps-rubella (MMR) vaccine, a threshold that helps prevent ...
The approval was based on data from the BLUE-C trial, which assessed the sensitivity and specificity of the Cologuard Plus test vs FIT in asymptomatic adults scheduled for screening colonoscopy.
(HealthDay News) — Harmful diagnostic errors (DEs) occur in an estimated one of every 14 hospitalized general medicine patients, according to a study published online Oct. 1 in BMJ Quality & Safety.
DFD-29 is an investigational formulation of minocycline hydrochloride delivered in a modified release capsule. The FDA is reviewing the NDA for DFD-29 as a potential treatment for adults with ...
(HealthDay News) — Tulisokibart, a tumor necrosis factor-like cytokine 1A monoclonal antibody, is more effective in inducing clinical remission in patients with moderately to severely active ...
The Food and Drug Administration (FDA) has granted Orphan Drug designation to LQT-1213, a first-in-class serum glucocorticoid regulated kinase 1 (SGK1) inhibitor, for the treatment of long QT syndrome ...
Navenibart is an investigational monoclonal antibody that blocks plasma kallikrein. The Food and Drug Administration (FDA) has granted Orphan Drug designation to navenibart for the treatment of ...
The approval was based on data from the randomized, double-blind, placebo-controlled, phase 3 CheckMate -77T trial.
Acalabrutinib, a Bruton tyrosine kinase inhibitor, is currently approved under the brand name Calquence ® for MCL in patients who have received at least 1 prior therapy. It is also indicated for the ...